Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity
- 30 August 2007
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 35 (12), 2149-2153
- https://doi.org/10.1124/dmd.107.015446
Abstract
Interindividual variability in the glucuronidation of xenobiotics metabolized by UDP-glucuronosyltransferase 1A9 (UGT1A9) suggests the presence of functional UGT1A9 variants. The aim of this study was to evaluate whether the putative functionality of the UGT1A9 variants–118T9>10 (rs3832043), I399C>T (rs2741049), –275T>A (rs6714486), and–2152C>T (rs17868320) could be confirmed in an independent study. UGT1A9 genotypes and UGT1A9 activity (i.e., flavopiridol and mycophenolic acid glucuronidation) were determined in 46 Caucasian human livers. mRNA levels were quantitated by real-time polymerase chain reaction in 35 of these livers. In addition, samples from 60 unrelated Caucasians belonging to the HapMap Project were also genotyped to confirm the allele frequencies and linkage disequilibrium (LD) pattern observed in our Caucasian livers. The allele frequencies of the–118T9>10, I399C>T, –275T>A, and–2152C>T variants were 0.39, 0.39, 0.02, and 0.02 in the livers, respectively. The I399C>T variant was in complete LD (r2 = 1) with–118T9>10 (linked alleles: C and T9, respectively). Complete LD between these two variants was also found in the HapMap samples (frequencies of–118T9>10 and I399C>T = 0.38). I399C>T and–118T9>10 correlated with neither UGT1A9 activities nor mRNA levels. Because of the low frequencies of the–275T>A and–2152C>T variants, an effect on phenotype could not be evaluated. Our data demonstrate that the common I399C>T and–118T9>10 polymorphisms do not explain interindividual variation in hepatic UGT1A9 activity and mRNA expression and are in complete LD in the donor liver samples we studied.Keywords
This publication has 26 references indexed in Scilit:
- THE NOVEL UGT1A9 INTRONIC I399 POLYMORPHISM APPEARS AS A PREDICTOR OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN GLUCURONIDATION LEVELS IN THE LIVERPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Isoform‐Selective Probe Substrates for In Vitro Studies of Human UDP‐GlucuronosyltransferasesMethods in enzymology, 2005
- Hepatic Expression of the UGT1A9 Gene Is Governed by Hepatocyte Nuclear Factor 4αPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Identification of common polymorphisms in the promoter of the UGT1A9 genePharmacogenetics, 2004
- THE MAIN ROLE OF UGT1A9 IN THE HEPATIC METABOLISM OF MYCOPHENOLIC ACID AND THE EFFECTS OF NATURALLY OCCURRING VARIANTSDrug Metabolism and Disposition, 2004
- HUMAN UDP-GLUCURONOSYLTRANSFERASES SHOW ATYPICAL METABOLISM OF MYCOPHENOLIC ACID AND INHIBITION BY CURCUMINDrug Metabolism and Disposition, 2004
- Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4Hepatology, 2004
- Cloning and Characterization of the Human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 Gene PromotersPublished by Elsevier BV ,2003
- The Monkey and Human Uridine Diphosphate-Glucuronosyltransferase UGT1A9, Expressed in Steroid Target Tissues, Are Estrogen-Conjugating EnzymesEndocrinology, 1999
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976